• Revenue grew 31% to $48.2 million
• EBITDA increased by 60% to $8.3 million
• Net Profit Before Tax up 62.1% to $6.3 million

Austco Healthcare Limited (Austco), a global leader in clinical communications solutions, announces record first-half revenues, growing EBITDA, and accelerating profit growth for the half-year ended 31 December 2025. Total 1H26 revenue was $48.2 million, an increase of $11.3 million, or 30.7%, compared to 1H25. Software and SMA revenues increased 9% to $5.0 million over the prior comparative period. Gross margin improved to 52.2% from 51.1%, demonstrating the operating leverage of the business model. EBITDA of $8.3 million in 1H26 was up 60.1% from $5.2 million in 1H25, driven by strong revenue growth and improving operating leverage. Net Profit Before Tax grew 62.1% to $6.3 million, up from $3.9 million in 1H25. Austco's Unfilled Contracted Revenue (UCR) stands at $47.2 million at 16 February 2026, highlighting the continued strength of new sales wins across the Group. The Company invested $2.5 million in research and development, of which $1.1 million was capitalised, in the continued development of its innovative nurse call and clinical communications platform, Tacera. Cash on hand was $15.2 million at 31 December 2025, and Austco Healthcare is debt-free.

No dividend has been declared, to allow the funding of organic and inorganic growth and the acquisition earn-out payments.

The consistent growth trajectory and improving operating leverage position the Company well for continued expansion. With strong market demand, a differentiated integrated product offering, and operational efficiencies flowing through to the bottom line, the Company is confident in its ability to sustain earnings growth into the second half and beyond.